GSK Gets Renewed Invitation to Human Genome Sciences Strategic Review

Date : 06/15/2012 @ 10:42AM
Source : Dow Jones News
Stock : Human Genome Sciences, Inc. (MM) (HGSI)
Quote : 14.24  0.0 (0.00%) @ 2:05AM

GSK Gets Renewed Invitation to Human Genome Sciences Strategic Review

GlaxoSmithKline (LSE:GSK)
Historical Stock Chart

5 Years : From Jul 2012 to Jul 2017

Click Here for more GlaxoSmithKline Charts.

LONDON--Pharmaceutical company GlaxoSmithKline PLC (GSK.LN) Friday confirmed that it has received a renewed invitation from Human Genome Sciences (HGSI) to participate in its strategic alternatives review process which started in April, and said it is continuing with its tender for the company.

MAIN FACTS:

-GSK continues to believe that participation in the process is unnecessary given the company's offer is not conditioned on due diligence or financing and can be completed expeditiously.

-Shares at 1405 GMT down 0.7%, at 1,449 pence valuing the company at GBP72.6 billion.

-Write to Ed Ballard at ed.ballard@dowjones.com

Latest HGSI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.